Filing Flows › Organogenesis Holdings (ORGO) › Free cash flow
Organogenesis Holdings (ORGO) free cash flow by quarter
Organogenesis Holdings' free cash flow was $18.0M in Q1 2026 (first quarter 2026), -48% from Q4 2025. Over the last 3 quarters it ranged from $844K (Q3 2025) to $34.8M (Q4 2025).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q1 2026 | $18.0M | -48% | — |
| Q4 2025 | $34.8M | 41× | — |
| Q3 2025 | $844K | — | — |
Q1 2026 at a glance
Organogenesis Holdings, Q1 2026: revenue $37.2M (-57% year over year), operating margin -185.1%, net loss $53.2M, operating cash flow $21.1M. The chart follows the revenue to costs, profit and cash.
Questions
What is Organogenesis Holdings' free cash flow?
Organogenesis Holdings' free cash flow was $18.0M in Q1 2026 (first quarter 2026), -48% from Q4 2025.
How has Organogenesis Holdings' free cash flow changed?
Over the last 3 quarters it ranged from $844K (Q3 2025) to $34.8M (Q4 2025).
Q1 2026 results → · How Organogenesis Holdings makes money →